Research in the Dermot Maher Lab focuses on cancer pain management. We aim to characterize the immunosuppression that occurs with the use of certain pharmacologic pain therapies, including opioids. We also study the relationship between this pharmacologically induced immunosuppression and the rate of manifestation and recurrence of certain types of malignancies. Our goal is to gain a broader understanding of the benefits and side effects of pain medication pharmacology in order to help patients suffering from painful and complex conditions, such as cancer, manage their symptoms more effectively.
Research in the Diane Griffin Lab focuses on the viral, cellular and immunologic determinants of diseases caused by alphaviruses and the measles virus. Our current studies aim to understand the immune-system mechanisms behind viral clearance and disease enhancement. Our team is also working to understand the pathogenesis of the measles virus, with a focus on developing new vaccines and learning how the virus induces immunosuppression.
The Vascularized Composite Allotransplantation (VCA) Research Lab is leading research aimed at warding against rejection and reducing the number of medications patients have to take for the rest of their lives. They’re testing a protocol that involves treating the patient with antibodies on the day of transplant, followed by a donor bone marrow infusion several days later. This protocol would allow patients to be treated with low doses of a single maintenance drug after being transplanted.